tyrosine + bupropion

This is a combination product containing the amino acid tyrosine (L-tyrosine) and bupropion hydrochloride. Tyrosine is a precursor to dopamine and other catecholamines, while bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) that weakly inhibits the reuptake of norepinephrine and dopamine from the synaptic cleft. The combination appears to be marketed as a kit formulation, potentially aimed at supporting dopaminergic neurotransmission through complementary mechanisms - tyrosine providing substrate for catecholamine synthesis and bupropion prolonging the action of these neurotransmitters in the synapse. Based on the search results, this appears to be a compounded or alternative formulation approach to depression treatment, though it is not a standard FDA-approved combination product like the established bupropion combinations (dextromethorphan/bupropion or naltrexone/bupropion).

Brand names

Appbutamone

Other names

L-tyrosine + bupropionAPPBUTAMONE-D